This review focuses on the potential for traumatic brain injury to evoke both focal and diffuse changes within the brain parenchyma, while considering the cellular constituents involved and the subcellular perturbations that contribute to their dysfunction. New insight is provided on the pathobiology of traumatically induced cell body injury and diffuse axonal damage. The consequences of axonal damage in terms of subsequent deafferentation and any potential retrograde cell death and atrophy are addressed. The regional and global metabolic sequelae are also considered. This detailed presentation of the neuropathological consequences of traumatic brain injury is used to set the stage for better appreciating the neurological recovery occurring after traumatic injury. Although the pathological and clinical effects of focal and diffuse damage are usually intermingled, the different clinical manifestations of recovery patterns associated with focal versus diffuse injuries are presented. The recognizable patterns of recovery, involving unconsciousness, posttraumatic confusion/amnesia, and postconfusional restoration, that typically occur across the full spectrum of diffuse injury are described, recognizing that the patient's long-term recovery may involve more idiosyncratic combinations of dysfunction. The review highlights the relationship of focal lesions to localizing syndromes that may be embedded in the evolving natural history of diffuse pathology. It is noted that injuries with primarily focal pathology do not necessarily follow a comparable pattern of recovery with distinct phases. Potential linkages of these recovery patterns to the known neuropathological sequelae of injury and various reparative mechanisms are considered and it is proposed that potential biological markers and newer imaging technologies will better define these linkages. Anatomy and Neurobiology, Virginia Commonwealth University, 1101 East Marshall St, PO Box 980709, Richmond, VA 23298 (e-mail: jtpovlis@ vcu.edu). each feature of TBI. Rather, it is organized as a series of vignettes dealing with important findings in the field with appropriate reference to other review articles addressing each of the considered themes. As little as 25 years ago, it was assumed that the major pathobiology of TBI was brain edema. Further, it was posited that if the brain edema could be understood and treated then all the morbidity and mortality associated with TBI would be reversed. As will be seen in the following passages, our understanding of TBI is now more complete, albeit this has introduced a new level of complexity. To date, the rationale driving the basic science and clinical investigation and assessment of TBI has varied, yet it has been based primarily on the recognition that TBI is a national healthcare problem, affecting 76
each feature of TBI. Rather, it is organized as a series of vignettes dealing with important findings in the field with appropriate reference to other review articles addressing each of the considered themes. As little as 25 years ago, it was assumed that the major pathobiology of TBI was brain edema. Further, it was posited that if the brain edema could be understood and treated then all the morbidity and mortality associated with TBI would be reversed. As will be seen in the following passages, our understanding of TBI is now more complete, albeit this has introduced a new level of complexity. To date, the rationale driving the basic science and clinical investigation and assessment of TBI has varied, yet it has been based primarily on the recognition that TBI is a national healthcare problem, affecting more than 2 million Americans per year. As many head-injured patients are young, their long-term care as well as their loss from the work force exacts significant personal and societal costs. In addition to the adverse implications of TBI for citizenry of the United States, this problem is also growing worldwide and, as such, will mandate increased international attention. In fact, it is predicted by the year 2020 TBI will be the third leading cause of death and disability in the world. 1 
NOMENCLATURE
The nomenclature currently used for the description of the type of TBI and its severity is not entirely satisfactory. Yet, at the moment, there has been little movement to refine existing terminology better. In the context of TBI, it is typical to speak of focal and diffuse lesions with the inference that these 2 identities do not overlap nor occur in the same patient. However, as has been recognized by Graham and colleagues as well as by others, particularly in the case of severe TBI, focal and diffuse pathologies coexist and contribute to morbidity. 2 Typically, focal change includes contusion and hematoma formation, whereas diffuse change includes diffuse axonal injury (DAI) and diffuse microvascular damage. In addition to these focal and diffuse abnormalities, there is now the recognition of more generalized abnormalities involving widespread neuroexcitation, and heterogeneous as well as global metabolic changes. In the following passages, we attempt to review these changes occurring in the injured brain to better appreciate the ensuing morbidity and recovery as well as their specific clinical assessment. First, traumatically induced cellular, subcellular, and metabolic abnormalities will be presented in the context of focal and diffuse change, realizing the inherent limitations of this terminology. In turn, this will be followed by a discussion of clinical assessment and natural history as informed by an understanding of the pathobiology of TBI. Realizing the complexity of multiple, interactive pathologic events after TBI and the inherent limitations of current terminology, the conceptual division will vary in the 2 sections. In the discussion of pathobiology, focal, multifocal, and diffuse damage will be considered within the categories of neuronal somatic, axonal, synaptic, and metabolic change. The section on clinical assessment and recovery will consider diffuse and focal injuries separately, recognizing that these are not mutually exclusive events and that each includes multiple types of subcellular, cellular, and physiologic dysfunction.
NEURONAL CHANGE: FOCAL AND DIFFUSE
The focal damage occurring with TBI is relatively straightforward and typically involves contusion and/or mass lesion formation. By means of direct and/or indirect contact/ destructive forces, damage to specific focal areas of the brain results in morbidity. Typically, contusions are the result of hemorrhagic lesions within the gray matter or at gray-white interface that most likely contribute to local neuronal destruction and ischemia, with its adverse consequences. In contusional and pericontusional domains, necrotic and apoptotic neuronal deaths have been identified in both animals and humans, and these forms of cell death have been the focus of major reviews. [3] [4] [5] Although neuronal death is routinely found within contusional and pericontusional sites, perhaps more intriguing are the more limited descriptions, in animals and humans, of diffuse neuronal damage and death. To date, hippocampal, cerebellar, and diffuse neocortical and diencephalic as well as scattered white matter cell deaths have been described after experimental TBI. [6] [7] [8] [9] [10] The diffuse cell death triggered by TBI appears to involve both necrotic and apoptotic death cascades, with the assumption that neuronal necrosis follows from membrane failure and the disruption of ionic homeostasis with the subsequent rapid degradation of the neuronal cytoskeleton and its cytoplasmic constituents. Typically, these neurons appear swollen with dilated mitochondria and pyknotic nuclei. In www.headtraumarehab.com terms of the apoptotic death cascade, the overall pathobiology is less clear with some arguing that either traumatically induced neuroexcitation, radical-mediated injury, or a dysregulation of calcium homeostasis contributes to the genesis of apoptotic change. [3] [4] [5] In contrast to necrosis, apoptosis is not directly linked to cell membrane perturbation or disruption. In fact, the neuronal cell membrane remains intact despite significant internucleosomal DNA strand breaks with nuclear condensation. These intranuclear changes signal the subsequent slow demise of the neuron unlike the rapid death seen with necrosis. [11] [12] [13] [14] [15] [16] [17] [18] Some have attempted to explain the traumatically induced apoptotic cell death pathway as a dysregulation of proapoptotic and antiapoptotic factors within the neuronal cell body with particular emphasis on the Bc1-2 family of genes. 4 In the context of white matter change, it has been argued that traumatically induced axonal injury (to be discussed below) and its associated wallerian degeneration evoke oligodendrocytic and glial cell death that also follow an apoptotic death cascade. 17, 18 In concert with this literature on diffuse apoptotic and necrotic death, recent findings suggest that other previously unappreciated factors may also be players in influencing neuronal perturbation and/or death. Specifically, through the use of extracellular tracers, Povlishock and colleagues have shown that the mechanical forces of injury mechanically disrupt scattered/diffuse neuronal cell membranes, allowing the influx of tracers normally excluded by intact cell membranes. 19 When these scattered neuronal cell bodies were followed over time, some underwent rapid necrotic cell death whereas others apparently reorganized, excluded further tracer penetration, and survived. The rapid cell death appeared linked to persistent membrane dysfunction/poration with the activation of cysteine proteases (calpain and caspase), causing the subsequent rapid degradation of the neuronal soma. On the basis of recent unpublished work, it appears that the surviving cells are capable of resealing their plasma membranes thereby restoring biological function and assuring their survival postinjury. These findings not only speak to the diversity of those neuronal changes occurring with TBI but also strongly suggest that mechanical injury itself directly acts on the neuronal cell body to elicit membrane perturbation. Thus, it is now clear that although neuroexcitation, radical-mediated damage, and calcium dysregulation can be contributors to neuronal cell loss and damage, the potential adverse consequences of the mechanical component of the injury should not be underestimated.
The inherent complexity associated with this traumatically induced neuronal damage is also attested to by parallel findings that those neuronal cell bodies linked to traumatically damaged axons (discussed below) show a different repertoire of change that, in most cases, does not progress to rapid cell death. Rather, contrary to the expectations of modern neuroscience which advocates that axonal damage, particularly that in relation to the sustaining neuronal soma, causes rapid neuronal cell death, [20] [21] [22] Povlishock and colleagues found that axonal injury, even in the perisomatic domain (ie, within 40-60 µm of the cell body), did not result in rapid death. 23 Rather, the injury triggered perturbation of neuronal protein translation that persisted for several days only to be followed by cellular recovery. 23 The long-term fate of these neurons remains to be determined; yet, the fact that the neurons survive in the early posttraumatic period suggests that they are not destined to die. Perhaps, over time, these neurons atrophy in response to the loss of their terminal projections, yet, this issue requires continued investigation.
MULTIFOCAL AND DIFFUSE AXONAL INJURY
While our understanding of both the focal and diffuse neuronal somatic responses associated with TBI is beginning to evolve, our appreciation of axonal injury in the context of TBI has become quite advanced, with a detailed mechanistic understanding now emerging. Like the above-disclosed scenario for traumatic injury to the neuronal soma, our oncesimplistic and unifying concept surrounding traumatically induced axonal injury has become more complex yielding new opportunities and challenges for further understanding and treating this devastating component of brain injury. Because DAI in TBI has been thoroughly addressed in several excellent reviews, [24] [25] [26] [27] [28] we will confine our comments to some of the latest advances in the field. Historically, on the basis of postmortem analysis, it has been recognized that traumatically induced injury can evoke scattered and/or multifocal axonal change throughout the subcortical white matter, corpus callosum, and brain stem. 2, 29, 30 Originally, it was thought that the shear and tensile forces of injury rapidly tore axons causing them to retract and expel a ball of axoplasm forming a swollen "retraction" ball, the pathological signature of traumatically induced axonal damage. More contemporary findings rejected this premise, noting that direct mechanical renting of the axon was not the norm. Rather, it was reserved only for the most severe forms of injury. It is now known that focal alteration of the axolemma occurs following TBI, 31, 32 and that this leads to progressive changes that impede axonal transport and subsequently result in the local swelling of the axon prior to detachment from its downstream segment. [33] [34] [35] Some have posited that this impairment of axonal transport is linked directly to local alterations in the axolemmal permeability, most likely triggered by the mechanical forces associated with injury. In this scenario, it is posited that the damaged axolemma allows the influx of normally excluded extracellular ions, such as calcium, that in turn activate the cysteine proteases, calpain and caspase, to disrupt the cytoskeleton. 36, 37 This, in turn, is believed to disrupt the local cellular substrates involved in anterograde/retrograde transport. Focal swelling of the axon then ensues via the continued delivery of substances via normal transport kinetics, leading to the collapse and detachment of the axon at this point of focal swelling. [33] [34] [35] [36] [37] In man, this process can take several hours to days postinjury 34, 35 suggesting that a window of opportunity exists over which therapeutic invention could be employed. To date, different therapies targeting various features of this traumatic axonal pathology have been used with some success. While beyond the scope of this review, the use of the immunophilin ligands, cyclosporin A and FK506, as well as hypothermia, has proved protective in the laboratory setting. [38] [39] [40] [41] [42] [43] [44] The precise targets of their protective actions remain to be fully elucidated; however, mitochondrial protection via the attenuation of mitochondrial permeability transition, calcineurin inhibition, and cysteine protease inhibition are most likely implicated in their protective effects. 27 Although much attention has been placed upon delayed axotomy and the finding of swollen axons that have become a neuropathologic and forensic signature of traumatic axonal injury, there is now the emerging concern that the focus on traumatic axonal swellings alone may significantly underestimate the overall magnitude of any traumatically induced axonal damage. Until recently, our laboratory as well as others had assumed that axolemmal change and cytoskeletal disruption always led to concomitant axonal swelling consistent with the repertoire change described above. However, recent studies using antibodies targeting cytoskeletal change and impaired axonal transport have shown, in both a qualitative and a quantitative fashion, that all axons manifesting cytoskeletal disruption do not necessarily progress to swelling (C. R. Marmarou et al, unpublished data, 2004) . Rather, it appears that in the most severely injured axons the magnitude of the axolemmal alteration and subsequent calcium influx led to a conversion of anterograde to retrograde transport thereby precluding swelling. These findings further illustrate the complexity of traumatically induced axonal injury and emphasize the fact that our current reliance upon one neuropathological marker may lead to a serious underestimation of the total magnitude of the axonal damage evoked by the traumatic injury. Further complexity is added to this issue in the recent work of Smith and colleagues, who have shown that, when unmyelinated/fine-caliber fibers www.headtraumarehab.com are mechanically loaded in vitro, they did not manifest the altered permeability changes described above. 46 Rather, they revealed mechanical perturbation of their sodium channels that resulted in the influx of sodium and subsequent depolarization with calcium entry through voltage-sensitive calcium channels and the reversal of the sodium-calcium exchangers. 46, 47 In these studies, Smith and colleagues posited that Na + channel activation was the pivotal event in elevating intracellular calcium that then contributed to the activation of the above-described protease cascades capable of disrupting the cytoskeleton and impairing anterograde transport. From Smith and colleagues' perspective, the pathology described above was not directly related to alterations in axonal permeability. Rather, they proposed that channel modification and subsequent ionic dysregulation were the culprits. 46, 47 Until recently, the field tended to minimize the contributions of Smith and colleagues in that they were made in an in vitro model using fine-caliber unmyelinated axons that were quite different from the large caliber, heavily myelinated axons typically investigated in both animals and humans. Further, conceptually, it was also difficult to fully integrate the findings made in vivo with those made in vitro. More recently, however, the overall implications of the findings of Smith and coworkers have become more meaningful in the continued investigation of traumatically induced axonal injury in animal models. Specifically, through electrophysiological assessments of compound action potentials in the corpus callosum, Reeves and colleagues dissected out those electrophysiological signals originating from myelinated axons versus fine-fiber unmyelinated axons. 48 Using slice preparations, they found that the traumatic injury was capable of altering compound action potentials in both unmyelinated and myelinated profiles, with the unanticipated finding that more significant electrophysiological damage occurred in the unmyelinated/finecaliber population of fibers. 48 This raises the intriguing possibility that unmyelinated/finecaliber axons are disproportionately vulnerable to the forces of injury and, as such, may be significant contributors to the ensuing morbidity associated with DAI.
As we currently do not have reliable neuropathological markers to delineate fine-fiber damage, it is quite possible that virtually all pathological studies to date, including those from our laboratory, have underestimated this potential. We have already noted that the identification of swellings alone may underestimate the total population of large caliber, myelinated axons sustaining traumatic axonal injury. Thus, this potential underestimation of the total axonal damage would be exacerbated by the failure to identify finecaliber/unmyelinated fiber damage.
These findings are of more than mere academic interest in that virtually all experimental, routine human postmortem, and forensic analyses have relied on the detection of swollen axonal profiles with the implication that they represent the full complement of traumatic axonal damage. In reality, however, they may represent only the "tip of the iceberg" in terms of total load of axonal damage in the brain, thereby calling into question clinical and basic science interpretations that have been derived from studies focusing on traumatic axonal swelling. Further, the consistent finding of unmyelinated/finefiber damage may have additional significance in that key intracortical connections are accomplished by unmyelinated fibers. For example, within the corpus callosum in subhuman primates, it has been estimated that 30% of the anterior aspect of the corpus callosum as well as the splenium contains unmyelinated fibers. 49 As the corpus callosum is a primary site of traumatically induced axonal change, damage to the fine-caliber fibers therein could contribute to a breakdown in interhemispheric communication, explaining some of the ensuing morbidity.
THE CONSEQUENCES OF DAI
One of the most important, yet unappreciated, consequences of DAI is the occurrence of downstream deafferentation/denervation. Specifically, following the above-described sequence of axonal damage and disconnection, the downstream axonal profile, disconnected from its sustaining soma, undergoes wallerian degeneration that in animals proceeds over the matter of weeks whereas in humans this wallerian change progresses over several months postinjury. 2 Concomitant with the breakdown of the myelin sheath and the axon cylinder, the downstream nerve terminals also undergo neurodegenerative change. Within 24 to 48 hours of injury, they manifest either increased electron density or neurofilamentous hyperplasia with detachment from their normal target sites. 50 This process has been observed in animals and humans, 50, 51 and although the overall degree of axonal terminal damage and deafferentation has not been quantified, there is the general impression that the amount of degenerating nerve terminals far exceeds the number of identified damaged fibers. This finding again adds credence to the premise that multiple fiber populations, including large caliber, myelinated as well as nonneuropathologically detected fine-caliber, myelinated, and unmyelinated fibers, may be involved. Although not well documented, the underlying assumption here is that such axonal degeneration and deafferentation contribute to the morbidity associated with DAI. Also important is the assumption that this deafferentation sets the stage for subsequent neuroplastic changes that can lead to either favorable-adaptive changes or, alternatively, less than optimal-maladaptive changes. To date, this issue has not been thoroughly investigated because neuroplastic responses are difficult to follow in the human brain.
Further, in the experimental setting, the diffuse nature of the injury complicates the conduct of rigorous assessment of any potential neuroplastic response. The limited data that exist suggest that in the case of mild to moderate TBI, diffuse deafferentation sets the stage for the sprouting of adjacent intact nerve fibers that, in many cases, leads to the recovery of significant synaptic input to the previously deafferentated neuronal domains. 51 In contrast with more severe injury, there is the suggestion of maladaptive change with the potential for inappropriate fiber ingrowth and/or cytoarchitectural modification. 52, 53 At present, studies are ongoing to better understand those factors involved in those neuroplastic responses triggered by the traumatic episode with manipulations of the extracellular environment being employed to delay and/or modify the ensuing postsynaptic sprouting response. Particular emphasis has been placed on the extracellular matrix and its postinjury proteolytic modification by means of matrix metalloproteinases. These metalloproteinases have been posited to prepare the denervated neuropil for synaptogenesis and thereby influence the spatial distribution of fiber nerve ingrowth. 54 Obviously, these issues require continued investigation to fully understand and thereby treat the downstream consequences of DAI.
METABOLIC CHANGE---MULTIFOCAL AND GLOBAL
One of the most exciting and promising areas related to the better understanding of the pathobiology of TBI centers on our current appreciation of the overall metabolic consequences evoked by the traumatic episode most likely occurring, in part, as a result of the cellular and mechanical changes described above. Recent studies have recognized, in animals and humans, a wide array of metabolic changes. As with the injurious processes noted above, these changes appear to involve regional, multifocal, and/or global abnormalities whose course and distribution may not remain static and may change over time. Over the last decade, efforts to detect metabolic change following TBI have been greatly aided by means of various technological advances including, but not limited to, the use of in vivo microdialysis, proton-magnetic resonance spectroscopy (MRS) and positron-emission tomography (PET), primarily using fluorodeoxyglucose to investigate glucose metabolism. These investigative tools have also been assisted www.headtraumarehab.com by other advances in imaging allowing for more complete appreciation of the precise injury that the brain had sustained, particularly in relation to diffuse injury. To date, T2-weighted spin echo sequences obtained using fluid attenuation inversion recovery as well as diffusion tensor imaging (DTI) have become extremely useful tools. 55 Using the above-identified approaches, a relatively intriguing story of metabolic change is beginning to evolve in the context of TBI.
A little over a decade ago, it was first recognized that the traumatic episode triggered a phase of neuroexcitation in which the excitatory neurotransmitter, glutamate, was considered to be a major player. 56, 57 Specifically, assessing animal models of TBI via regional microdialysis, extracellular glutamate was recognized to be significantly elevated postinjury, with the suggestion that the increased excitatory neurotransmitter levels participated in abnormal agonist-receptor interactions leading to either cell injury or death. 57, 58 In various animal models, this rise in extracellular glutamate was dramatic, yet brief. 57 Yet, because of the high extracellular levels seen, it was assumed that this excitatory transmitter was a major cause of the ensuing morbidity. This impression was also supported by the finding that the use of various receptor antagonists provided significant neuronal and behavioral protection. 59, 60 In the clinical setting, Bullock and colleagues provided more information supporting the potential for traumatically induced neuroexcitation, demonstrating via microdialysis probes placed in the injured brain that elevated glutamate levels occurred in humans after traumatic injury and that the overall magnitude and duration of this elevation correlated directly with the patient's outcome. [61] [62] [63] Despite this relatively compelling evidence advanced in the clinical laboratory implicating glutamate, clinical trials utilizing glutamate antagonists have not proved successful. 59, 60 This negative finding is comparable to those negative findings reported using the same antagonists in stroke. 64 The failure of these antagonists in TBI may be related to the fact that the neurotransmitter storm caused by traumatic episode also releases other excitatory and inhibitory transmitters that modulate the overall adverse consequences of the elevated glutamate. Alternatively, glutamate levels assessed by microdialysis may have poorly correlated with that observed in the synaptic cleft. In concert with this emerging appreciation of neuroexcitation following TBI, more recent studies have also focused on other metabolic consequences of injury, specifically in relation to altered glucose metabolism.
In the animal models, TBI has been shown to cause a widespread hyperglycolysis that persists for relatively brief periods only to revert to a hypoglycolytic state, which appears to persist until the animal recovers. 57, [65] [66] [67] [68] Using fluorodeoxyglucose and PET, Bergsneider and colleagues have observed comparable sequence of change in traumatically braininjured humans with the caveat that the temporal profile differed in animals versus humans, and that the course of metabolic change in humans is more elongated. 69 In the first several days postinjury in humans, regional cortical hyperglycolysis was observed. 69 Then, over a relatively prolonged posttraumatic period ranging from days to weeks, this hyperglycolytic phase transforms to reduced glucose metabolism, with the inference that this period of reduced glycolysis persists until the patient recovers. [70] [71] [72] Somewhat surprising in these studies was the finding that this profile of hyperglycolysis followed by reduced glucose utilization appeared similar in patients who had sustained severe versus mild TBI 70 ; however, it is possible that the lack of parallel assessments of CMRO 2 limited the overall interpretation of these findings.
Since the initial description of these metabolic changes linked to TBI, the last several years have witnessed considerable advances in our understanding of these changes, primarily in relation to glucose metabolism through an integration of PET, NMR spectroscopy, and microdialysis studies. Specifically, through these efforts, the above observations have been reconfirmed. Moreover, now a better understanding of the regional and heterogeneous responses, as well as potential alterations in various kinetic parameters, has emerged. Specifically, it is now recognized that in the first week postinjury, heterogeneous brain regions, particularly those in the pericontusional domains, demonstrate increased glucose metabolism with a concomitant decline in extracellular glucose as determined by means of microdialysis. 72, 73 Paralleling these changes in glucose, elevated lactate is also recognized in the microdialysate. Additionally, the use of NMR spectroscopy in the same regions demonstrated reduced N-acetyl aspartate (NAA) and creatine levels, with the reduction of NAA thought to reflect impaired mitochondrial function and an inability to make adenosine triphosphate. 73 The assumption here is that this increased glucose utilization occurs with metabolic stress, perhaps in an effort to maintain cellular homeostasis in the face of an evolving neuropathological change leading to cell death. These observations are important because patients with worse outcome tend to have higher glutamate and lactate and reduced glucose values than do those with a good outcome. 62 It is important to note that these findings are regionally heterogeneous as abnormal glucose utilization and extracellular glucose and lactate levels can be observed in damaged brain regions interspersed with other brain tissue showing a normal metabolic profile.
Again, as reported above, these same patients appeared over time to show a more global reduction in glucose metabolism, perhaps as a consequence of the above-described acute metabolic and pathologic changes. As alluded to previously, the overall implications of this reduced glucose metabolism in relation to recovery remain unclear. Recent studies, however, provide new information on this issue through the assessment of the uptake, transport, and hexokinase activity of 18 F-FDG. 74 In these elegant studies, the authors observed that following TBI the glucose transporter activity is relatively preserved while the hexokinase activity is reduced. The enzyme hexokinase is responsible for phosphorylating the 18 F-FDG and trapping it within the cell and hexokinase is strongly inhibited by its product, glucose-6-phosphate. Therefore, reduced hexokinase activity may translate into a regional accumulation of glucose-6-phosphate that, as such, may suggest a reduction in the overall metabolic activity of glucose.
NEUROPATHOLOGIC AND METABOLIC CHANGE AND THEIR RELATIONSHIP TO NEUROLOGICAL RECOVERY FOLLOWING TBI
As will be discussed in the following passages, our current linkage of specific structural and metabolic changes to neurological recovery is tenuous. At present, many tend to disassociate the neuropathological damage described above in the neuronal soma, axons, and their terminals from the ongoing metabolic changes that are perceived to involve abnormal mitochondrial function, increased glucose metabolism, and altered ionic homeostatis. In our estimation, however, these 2 events are most likely interrelated and both most likely participate in the morbidity and recovery associated with TBI. Cell loss, axonal damage, and target deafferentation resulting from both contusional and diffuse white matter change can have global metabolic effects by disconnecting tens of thousands of neurons and, thereby, altering their functional interactions. This may explain how regional and/or diffuse injury can lead to global dysfunction. Obviously, this issue remains to be critically evaluated. Yet, one is confident that over the next 20 years through a better integration of modern imaging, interfaced with microdialysis, MRS and PET scanning, a more detailed appreciation of the interaction of these events and their overall implications for neurological recovery of the patient will emerge. Even without a fully integrated picture, our present understanding of the pathophysiology of TBI has important implications for clinical assessment and recovery and, accordingly, the following sections will discuss these implications.
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NEUROPATHOLOGICALLY BASED CLINICAL ASSESSMENT
An understanding of the pathophysiology of TBI is extremely useful in formulating clinical diagnosis during the rehabilitation of patients with TBI. It promotes better understanding of clinical consequences, informs prognosis, and can guide rehabilitation planning. Further, neuropathologically based diagnosis and prognosis help clinicians determine when clinical syndromes do not fit the expected path of recovery, suggesting possible secondary neurologic complications, the influence of noninjury factors (medical, iatrogenic, or psychogenic), or misdiagnosis of injury type and severity. Unfortunately, pathophysiologically based diagnosis can be difficult because of a lack of specific clinical probes and biological markers for some diffuse and secondary components, and the difficulty parsing out individual components when there is a mix of multiple pathologic and metabolic processes. Newer imaging techniques hold promise to provide better indices of CNS damage.
Although, as previously discussed, focal and diffuse pathological processes are often intermingled and have common secondary and metabolic consequences, it is useful to consider them separately for the purposes of clinical diagnosis. Division into focal, diffuse, primary, and secondary categories can facilitate neurologic evaluation and neuropathologically based diagnosis. Table 1 proposes a matrix of this categorization. 
CLINICAL ASSESSMENT AND NATURAL HISTORY OF DIFFUSE INJURY
Diffuse and multifocal pathology consists of DAI, microvascular damage, and all of the associated components that cause neuronal injury, including mechanical damage, diffuse hypoxic-ischemic injury, excitotoxicity, and a host of other pathophysiologic events alluded to earlier. The various components of diffuse injury are impossible to separate on a clinical basis. Suspicion for substantial secondary neuronal injury may be raised when there are documented secondary insults such as prolonged increases in intracranial pressure, decreases in systemic blood pressure, or hypoxia. 75, 76 Even without such secondary stressors, the complete picture of diffuse brain injury includes some mix of DAI plus associated neuronal injury, and a variety of reversible and irreversible pathophysiologic events.
There are no commonly available clinical markers of DAI and any accompanying secondary events. Clinical diagnosis depends on the following criteria: (1) accelerationdeceleration mechanism consistent with the apparent severity of the injury; (2) immediate loss of consciousness, except for the most mild diffuse injuries; and (3) findings on structural neuroimaging (computed tomography [CT] or magnetic resonance imaging [MRI] ) that are consistent with DAI include diffuse edema, petechial hemorrhages, nonhemorrhagic macroscopic white matter lesions, and small subarachnoid and intraventricular hemorrhages. 77, 78 Imaging may show none of these abnormalities in mild or moderate diffuse injuries, and abnormalities may be subtle even in more severe injuries. The MRI demonstrates more lesions than CT, but CT is still a more practical emergency tool for rapid imaging of patients to demonstrate acute hemorrhagic lesions and to accommodate critical patients tied to emergency equipment. If present, deeper lesions correspond to more severe injuries and greater disability. 79, 80 Histopathologic analysis has supported the relationship of the depth of focal hemorrhagic lesions sometimes associated with DAI and the severity of DAI. 81 In addition to the white matter of the cerebral hemispheres (grade 1), involvement of the corpus callosum (grade 2), or additionally the dorsolateral upper brain stem (grade 3) corresponds to more severe levels of DAI. Over time, the degree of atrophy that can be measured by various volumetric techniques, such as ventricular brain ratio, quantitative MRI, 82, 83 or corpus callosum volume, 84 does correlate with injury severity and clinical outcome. Bigler 85 has demonstrated that atrophic changes evolve over months, and even over a year postinjury. Newer imaging techniques, such as MR spectroscopy, may offer a window on severity of diffuse injury at earlier stages (see below).
Biomarkers of brain injury are being developed to provide a window on diffuse damage, secondary injury, and response to treatment. One promising area of investigation is the measure of proteolytic damage, reflecting activity of proteases such as caspase and calpain involved in necrosis and apoptosis. Measures of proteins and their proteolytic fragments released into the spinal fluid with neuronal damage (eg, alpha II spectrin) have shown a fairly strong relationship with traumatic brain damage in rodent models and are being studied in human TBI. 86, 87 They are not yet ready for clinical use.
The clinical consequences of diffuse injuries are still the most widely used clinical indicators of injury severity. The usual measures describe either the severity of particular clinical problems at index times postinjury or the duration of recognized clinical periods of recovery. The traditional indices of injury severity-acute Glasgow Coma Scale (GCS) 88 score, duration of unconsciousness (LOC), and duration of posttraumatic amnesia (PTA)-are examples of such measures. Other measures may stand in as severity indices, such as Functional Independence Measure (FIM) scores at rehabilitation admission or discharge, neuropsychological batteries, or outcome scales applied at particular intervals after injury.
The natural history of diffuse pathology follows a generally recognizable pattern of recovery that occurs in a similar fashion across the spectrum of severity. Although patients with primarily focal pathology may display some, or all, of the components of this pattern, the course of recovery does not necessarily follow as predictable a pattern as those with primarily diffuse pathology. 89, 90 The time course and severity of consequences along the path of recovery has a relationship with the quantity of diffuse pathology, 91, 92 albeit difficult to accurately quantify all the components of the injury. This natural history may be broadly described in the context of 3 principal phases of recovery from the acute to chronic stages that form the basis for the main severity indices noted above. The first is unconsciousness, which occurs immediately postinjury, without lucid interval. The next phase is a proportionally longer period of emerging consciousness and confusion, closely linked to dense anterograde amnesia (PTA). Following resolution of confusion and PTA is a yet, proportionally longer phase of postconfusional restoration of cognitive function. The duration of these phases and severity of impairments within each phase largely correspond to the severity of diffuse injury. Their proportionality can be the basis for predicting time course of recovery and outcome. 90 Patients with the least severe diffuse injuries (mild concussion) evolve through unconsciousness (if complete loss of consciousness occurs at all) in seconds to minutes and through the confusional state usually in minutes to hours, followed by a postconfusional recovery period typically lasting www.headtraumarehab.com days to weeks. The transition through the earliest stages may be brief, unwitnessed, and difficult to recognize. Patients with severe TBI may require days to weeks to evolve through unconsciousness, weeks to months to resolve confusion and PTA, and months to years to evolve through the postconfusional residual recovery period. The course of recovery after severe TBI is among the longest observed after neurologic damage, and numerous studies have demonstrated dynamic changes in neuropsychological and social functioning up to 5 years postinjury. [93] [94] [95] [96] Those with the most severe diffuse injuries may stall at some stage in this recovery process (eg, permanent vegetative state 97 or minimally conscious state 98 ). As pointed out, these phases of recovery appear to be proportionally related in patients with diffuse injury, each subsequent phase is severalfold longer than the previous one. 16 This proportionality, though highly variant, can be useful for clinical planning and prognosis. For instance, there was a predictable relationship between the duration of unconsciousness (LOC) and duration of confusion/PTA in a series of patients with diffuse injury defined by a linear regression Table 2 . Braintree neurologic stages of recovery from diffuse TBI (and corresponding Rancho Los Amigos Scale levels) 1 . Coma: unresponsive, eyes closed, no sign of wakefulness (Rancho 1) 2. Vegetative state/wakeful unconsciousness: no cognitive awareness; gross wakefulness, sleep-wake cycles begin (Rancho 2) 3. Minimally conscious state: inconsistent, simple purposeful behavior, inconsistent response to commands begin; often mute (Rancho 3) 4. Confusional state: interactive communication and appropriate object use begin; amnesic (PTA), severe basic attentional deficits, hypokinetic or agitated, labile behavior; later more appropriate goal-directed behavior with continuing anterograde amnesia (Rancho 4, 5, and partly 6) 5. Postconfusional/evolving independence: marked by resolution of PTA; cognitive impairments in higher level attention, memory retrieval, and executive functioning; deficits in self-awareness, social awareness, behavioral and emotional regulation; achieving functional independence in daily self-care, improving social interaction; developing independence at home (Rancho 6 and partly 7) 6. Social competence/community reentry: marked by resumption of basic household independence; developing independence in community, household management skills, and later returning to academic or vocational pursuits; recovering higher level cognitive abilities (divided attention, cognitive speed, executive functioning), self-awareness, social skills; developing effective adaptation and compensation for residual problems (Rancho 7 and 8) model 90 -PTA (weeks) = 0.4 × LOC (days) + 3.6. This model was confirmed in a separate cohort of 228 patients. 99 A large proportion of patients with moderate to severe injury had PTAs extending 3 to 4 weeks, even with relatively brief LOC. Age more than 40 years or the presence of a focal frontal lesion was a significant additional influence, prolonging the duration of PTA in relation to the duration of unconsciousness.
The pattern of recovery outlined above has been further described according to various schemas. The most widely used is the Rancho Los Amigos levels of cognitive functioning. 100 Another schema, first proposed by Alexander 101 and further modified, 77 follows more traditional neurologic nomenclature (see Table 2 ). As patients progress through these stages, the principal defining cognitive limitations evolve from deficits in arousal and consciousness, to basic attention and anterograde amnesia, to higher level attention, memory, executive functioning, processing speed, insight, and social awareness. 102 It deserves emphasis again that not all patients will progress through all of these stages of recovery, in large part related to severity of diffuse injury, secondary complication, or, possibly, the residual effects of focal damage.
Numerous studies have demonstrated a relationship between clinical severity measures (GCS, LOC, and PTA) and various types of outcome measures (neuropsychological, functional disability, levels of handicap) at different times postinjury. 89, [103] [104] [105] [106] [107] [108] [109] [110] The strength of the relationship varies with the population studied, time postinjury, and how severity and outcome are measured. For instance, GCS and LOC are more powerful predictors of outcome for patients with primarily diffuse, rather than primarily focal, injury. 90, 111 LOC as measured by time to follow commands is a better predictor than the time to motor localization 112 and PTA as measured by word list learning may be a more sensitive predictor of outcome than the Galveston Orientation and Amnesia Test, 113 which emphasizes orientation. 114 The PTA is a better predictor of functional outcome than LOC and GCS in patients with diffuse injury 90 and in predicting return to work at 1 year. 107 Although injury severity measures such as LOC have a significant relationship with outcome as much as 5 years postinjury, 103, 104 injury severity variables are less sensitive predictors of outcome at times more remote from injury. 96, 115, 116 The precise relationship of the pathophysiologic components of diffuse injury and the clinical consequences at different stages of recovery is not well understood. Unconsciousness, posttraumatic confusion (PTA), and residual postconfusional deficits are likely related to specific and interacting effects of primary and secondary components of diffuse injury and the secondary components of focal injury as they evolve over time. For instance, posttraumatic coma and subsequent amnesia may result from a combination of mechanically induced depolarization, pontine cholinergic, and other neurochemical surges, along with any damage to structures in the brain stem, diencephalon, hippocampus, and thalamocortical connections critical for arousal, attention, and anterograde amnesia. Shaw 117 reviewed vascular, reticular, centripetal, pontine cholinergic, and convulsive theories of unconsciousness after concussion, and concluded that mechanically induced depolarization and synchronized discharge of cortical neurons, analogous to a convulsive discharge, was the best explanation. Other researchers 74 have found a correlation of reduced cerebral metabolic rate of glucose in the brain stem, thalamus, and cerebellum with level of consciousness in patients recovering from TBI. Global cortical reductions of glucose metabolism do not correlate with level of consciousness. 70 Global cerebral metabolic dysfunction probably correlates with other clinical aspects of recovery. As described earlier, animal models and human FDG-PET studies 72 demonstrated that cerebral metabolism follows a triphasic pattern of brief hypermetabolism, followed by a period of depressed metabolism and subsequent recovery of metabolic activity. As referred to previously, Wu and colleagues 72 observed that the period of reduced metabolic activity, as reflected by the cerebral metabolic rate of glucose, extends about 4 weeks, independent of injury severity. How this cortical depression correlates with the clinical consequences of diffuse injury is yet to be determined. We speculate that it may be related to the duration of posttraumatic confusion and PTA in patients with moderate or severe diffuse injuries or more subtle cognitive effects after mild diffuse injuries.
Although the early clinical consequences of diffuse injury may be largely determined by dynamic and reversible physiologic events, the severity of residual clinical problems in large part relates to the extent of primary and secondary axonal and neuronal damage, and the success of synaptic reorganization. 50 Some features of the diffuse injury syndrome may relate to the usual anatomic distribution of DAI, concentrated in the parasagittal frontal white matter, corpus callosum, and brain stem. 29, 78, 81 Another explanation of the typical syndrome is that DAI has more prominent impact on neurologic functions, such as attention and executive functioning, with highly distributed neural networks, making www.headtraumarehab.com them vulnerable to widely dispersed or multifocal damage. As the density of DAI increases and anatomic distribution widens with injuries of greater severity, the effects on these functions worsen and the likelihood of affecting other neurologic domains increases. For example, motor problems, including dysarthria, paresis, spasticity, imbalance, and gait disorders, are more prevalent in patients with more severe injuries. Owing to its diffuse, multifocal distribution, patients with DAI tend to have less predictable, idiosyncratic combinations of motor impairments than patients with focal pathology involving discreet, unilateral descending motor pathways. As a consequence, recovery of motor abilities after diffuse injury, such as ambulation or arm function, appears to have a better prognosis, along a more protracted course than similar problems after focal damage.
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CLINICAL ASSESSMENT AND NATURAL HISTORY OF FOCAL INJURY
As with focal pathology of other causes, the natural history of focal pathology after TBI is largely dependent on lesion characteristicslocation, size/depth, bilaterality (especially involving homologous areas), and secondary damage. Secondary injury may be the result of localized mass effect, hypometabolism, or secondary neuronal injury in adjacent or ipsihemispheric areas. 57, 74 Focal lesions are not directly associated with unconsciousness unless there is significant secondary mass effect, direct bilateral effects on the mesencephalon or diencephalon, or associated diffuse injury. The PTA is common with focal injuries 120 and may result from secondary metabolic and excitotoxic effects associated with the focal lesion or concomitant diffuse injury.
The usual location of focal cortical contusions (FCCs), the principal form of focal pathology, in the limbic and heteromodal association areas of the anterior frontal and temporal lobes, defines its typical cognitive and behavioral effects: impairments in executive functioning, working memory, memory encoding and retrieval, higher order attention, and behavior modulation. Other locations may present different problems. For instance, temporal contusions extending more posteriorly in the left temporal association areas may cause language disorders, characteristically anomic or trancortical sensory aphasia. Small differences in the depth of the lesion, involving a greater proportion of white matter pathways as they converge at deeper levels, can make large differences with respect to clinical effects and recovery. Further, bilateral involvement may portend a much worse prognosis and, conversely, patients with unilateral lesions, particularly involving less lateralized neural systems (eg, prefrontal), can have considerable recovery. 121 The specific clinical effects of focal pathology are often embedded in the evolving clinical recovery of diffuse injuries in patients with both categories of pathology. For instance, in addition to the effects that diffuse injury has on attention, memory, and executive functioning, patients with left perisylvian contusions may display an aphasic syndrome or patients with a basal ganglia area hemorrhage may have spastic hemiparesis. 122 Detection of particular localizing syndromes may be difficult until unmasked after resolution of posttraumatic confusion. Further difficulties in distinguishing effects of focal lesions arise because neurobehavioral syndromes may be identical to those related to diffuse injury (eg, dysexecutive syndrome; behavioral dysregulation). 111 Although problems are similar, recovery and prognosis may be different. For instance, features of the frontal lobe syndrome may be more persistent in patients with frontal FCC. 85, 123 Levin et al 124 observed that although other aspects of recovery were similar, unilateral frontal lesions adversely affects psychosocial outcome in children with TBI compared to those without focal frontal lesions. Particularly with more severe diffuse injuries, overall outcome is driven largely by the effects of diffuse injury rather than by those of focal injury. 125 Focal lesions may worsen prognosis, especially if associated with significant mass effect, shift, herniation, or other forms of secondary injury. [126] [127] [128] In patients with mild to moderate diffuse injury, large focal lesions may have more influence on recovery. 120, 129, 130 Clinical diagnosis of focal pathology is by neuroimaging. The MRI reveals more lesions than does CT. 131 Functional imaging usually reveals that the area of metabolic dysfunction extends well beyond the area of the structural lesion. 74 The correlations between focal lesions noted on neuroimaging and outcome have been modest, at best. A number of studies failed to demonstrate any robust relationship between lesion location (frontal, temporal, or otherwise) and neuropsychological performance. 130, [132] [133] [134] There may be several reasons for the weak relationship: (1) the effect of diffuse injury and secondary injury distal to the focal lesion may blur the distinct contribution of focal lesions; (2) group studies may miss specific brain-behavior relationships that require more fine-grained analysis of lesion size and location; (3) neuropsychological and other outcome measures may lack sensitivity to particular focal cognitive or behavioral deficits.
FUTURE OF CLINICAL ASSESSMENT OF DIFFUSE AND FOCAL TBI
Improvement in neuropathologically based diagnosis will come with clinically useful biomarkers and imaging technologies. The main problem is quantifying the mix of diffuse, focal, and secondary pathologies. Diffuse injuries present the greatest challenge. As discussed earlier, protein biomarkers and newer imaging technologies have the potential to provide a more direct window on the effects of DAI, associated secondary pathology, and metabolic change. The DTI can visualize disruption of white matter connections and potentially quantify white matter injury. 135, 136 The MRS allows for quantification of neurometabolites that are specific to the effect of TBI. Substances of interest are N-acetylaspartate (NAA), a marker of neuronal integrity that declines following TBI of all severities, and choline-containing compounds (Cho) which increase indicating membrane breakdown. These markers have significant relationships with GCS, PTA, cognitive function, and outcome after TBI of all severities. [137] [138] [139] [140] [141] [142] Functional imaging can better delineate the effects of diffuse injury than structural imaging. "Resting" studies using PET and SPECT demonstrate areas of hypometabolism and hypoperfusion, regions that may be normal on structural imaging. 143 A PET study of patients with DAI and no focal lesions showed significant association of attention, speed of processing, and executive functioning on neuropsychological measures with metabolism in the mesial and anterior prefrontal cortex. 145 Memory impairments were associated with mesial and dorsolateral frontal, but not with temporal hypometabolism. Functionally activated brain imaging using O-15 PET and functional MRI measures brain activity during specific motor or cognitive tasks and can illustrate how differently brain regions reallocate and reorganize function after brain injury. These methods can provide insights into brain recovery and response to treatment after TBI. For instance, patients with DAI demonstrated similar patterns but broader and additional areas of activation in tasks requiring working memory 145 and memory retrieval. 146 The merging of structural and functional imaging technologies for clinical use should provide better analyses of diffuse and focal injury severity and more reliable predictors of outcome in the near future. 
